Erasca (ERAS) Income from Continuing Operations (2020 - 2026)

Erasca (ERAS) reported Income from Continuing Operations of 183462000.0 for Q1 2026, down 492.46% on a YoY basis from 46746353.1 in Q1 2025, and down 531.8% quarter-over-quarter from 29038000.0 in Q4 2025.

Erasca (ERAS) Income from Continuing Operations (2020 - 2026) Analysis & Trends

Erasca has reported Income from Continuing Operations for 7 years, with the latest figure at 183462000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Income from Continuing Operations fell 492.46% year-over-year to 183462000.0; the trailing twelve-month figure through Mar 2026 stood at 276951000.0 (down 77.57% YoY), and the FY2025 full-year result was 124546000.0, up 22.95% from the prior year.
  • Income from Continuing Operations for Q1 2026 stood at 183462000.0, down from 29038000.0 in the prior quarter.
  • The five-year high for Income from Continuing Operations was 29038000.0 in Q4 2025, with the low at 183462000.0 in Q1 2026.
  • Historically, Income from Continuing Operations has averaged 49163764.71 across 5 years, with a median of 33199000.0 in 2023.
  • Annual changes were most pronounced in 2023 — Income from Continuing Operations jumped 78.04% — and 2026, when it plunged 492.46%.
  • Erasca's Income from Continuing Operations stood at 135250000.0 in 2022, then jumped by 78.04% to 29701000.0 in 2023, then dropped by 2.45% to 30429000.0 in 2024, then climbed by 4.57% to 29038000.0 in 2025, then slumped by 531.8% to 183462000.0 in 2026.
  • The last three Income from Continuing Operations figures came in at 183462000.0 (Q1 2026), 29038000.0 (Q4 2025), and 30575000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -26.94 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -2.97 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 30.80 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -3.40 Mn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -14.46 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -1.50 Mn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 1.03 Bn
9 Abivax 91.96 Bn 91.96 Bn - -56.48 Mn
10 Erasca 4.16 Bn 3.92 Bn - -183.46 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -183.46 Mn
Dec 31, 2025 -29.04 Mn
Sep 30, 2025 -30.58 Mn
Jun 30, 2025 -33.88 Mn
Mar 31, 2025 -30.97 Mn
Dec 31, 2024 -30.43 Mn
Sep 30, 2024 -31.37 Mn
Jun 30, 2024 -63.20 Mn
Mar 31, 2024 -35.02 Mn
Dec 31, 2023 -29.70 Mn
Sep 30, 2023 -30.36 Mn
Jun 30, 2023 -31.78 Mn
Mar 31, 2023 -33.20 Mn
Dec 31, 2022 -135.25 Mn
Sep 30, 2022 -35.49 Mn
Jun 30, 2022 -35.61 Mn
Mar 31, 2022 -36.46 Mn
Dec 31, 2021 -30.97 Mn
Sep 30, 2021 -46.07 Mn
Jun 30, 2021 -28.21 Mn